Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-04-09-Speech-3-380"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-04-09"^^xsd:date2
dcterms:Is Part Of	lp_eu:Human tissues and cells2
dcterms:Language	"fi"^^xsd:language2
lpv:document identification number	"en.20030409.7.3-380"2
lpv:hasSubsequent	lp_eu:2003-04-09-Speech-3-3812
lpv:speaker	lp:Eija-Riitta Korhola2
lpv:spokenAs	member; EPP-ED (1999-07-20--2004-07-19)3 unknown; Suomen kristillisdemokraatit rp (2001-05-30--2004-07-19)3 member; Delegation to the EU-Latvia Joint Parliamentary Committee (2002-02-07--2004-04-30)3 member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3 substitute; Committee on Foreign Affairs, Human Rights, Common Security and Defence Policy (2002-01-17--2004-07-19)3
lpv:translated text	"Mr President, I attach great value and give my full support to Doctor Liese’s work in this report, which establishes guidelines for the processing of human tissue in the European Union, which we also call a community of values. This is a vast subject, so I will just focus on one detail: the processing of stem cells. It is part of a direct continuum with the work we tried to do in Parliament’s Temporary Committee on Human Genetics the year before last. We got the message: the business aspect was the hottest area. Investors were in expectant mood. Expectations were not so much connected with new medical breakthroughs, but mainly the possibility of making lots of money. The following business hype applies to the field of genetic engineering: you expect to get at least as much for your money out of it as you would out of IT. In the end what is actually discovered in the research studies does not matter that much. While we waited for the hype, the fact that there was also an alternative to the cloning of embryonic stem cells – treatment with adult stem cells – was entirely overlooked. Of course, embryonic stem cells have a greater capacity for differentiating into any sort of tissue. Recently, however, studies have also opened up promising possibilities in the use of adult stem cells. The first cells in the human embryo are ‘totipotent’, which means they can differentiate into any cell type. Pluripotent stem cells, on the other hand, can differentiate into any cell type but they can no longer be used to create a new human being. Multipotent stem cells can only produce the cells of a certain tissue type, such as nerve, liver or blood cells. These are also found in adult cells, and it is those that are more interesting from the point of view of therapeutic cloning. The latest research points to the fact that some stem cells thought to be multipotent might well be pluripotent. This would mean that there would be no need to make stem cell chains from human embryos after all. Mr Liese’s report recognises the situation for what it is absolutely correctly, at the same time recognising the ethical problems that are encountered in the processing of embryos. It is important to say here that a medically sound approach and one that shows ethical wisdom are not necessarily mutually exclusive. We Christian Democrats say an emphatic ‘yes’ to research, at the same time wishing to preserve the sanctity of human dignity right from its frail beginnings."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph